Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand

Sponsor
Robert Wood Johnson Barnabas Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05003596
Collaborator
Brielle Orthopedics (Other), University Orthopedics Associates (Other)
60
2
2
24
30
1.3

Study Details

Study Description

Brief Summary

Steroids are often prescribed for their anti-inflammatory effects in patients with musculoskeletal injuries. Studies have shown that steroids may reduce pain and swelling, but their effects on range of motion and functional outcomes have not been illustrated. With this study, we aim to evaluate the effect of steroids on range of motion and functional outcomes in non-operatively managed musculoskeletal injuries of the hand.

Condition or Disease Intervention/Treatment Phase
  • Drug: Methylprednisolone Tablet
  • Other: Standard Mobilization Treatment
Phase 2/Phase 3

Detailed Description

Previous studies have investigated the effect of steroids on bone healing, edema reduction and postoperative pain. However, there seems to be a lack of literature on whether the use of steroids for their anti-inflammatory effects actually lead to improved range of motion and functional capacity. If the data shows that steroids do indeed help patients achieve increased functional outcomes, they may be used with higher confidence in their beneficial contribution to patient treatment and quality of life. If, however, the data show that steroids do not confer a significant benefit, they can be disregarded as they will avoid the risks associated with steroid use. We aim to investigate if the use of methylprednisolone will result in significantly improved ranges of motion and self-reported function compared to a control group at each measurement time point.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
data without intervention identification will be analyzed by outcome assessor
Primary Purpose:
Treatment
Official Title:
Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Steroid Group

Patients receive 21 tablets of 4 mg methylprednisolone to be taken by mouth over a 6 week taper. Patients will be advised to not take other anti-inflammatory medications like NSAIDs.

Drug: Methylprednisolone Tablet
Subjects will take a quantity 21 4mg tablets over a 6 week taper.
Other Names:
  • Solu-Medrol Dosepak
  • Active Comparator: Control Group

    Patients will recieve standard treatment that focuses on mobilization and stabilization using common techniques like buddy taping and splinting. Pain control will be managed using non-NSAID medications like Tylenol or opioid narcotics when deemed medically necessary.

    Other: Standard Mobilization Treatment
    standard treatment of hand injuries with focus on mobilization. No anti-inflammatory medications. Pain management via Tylenol or narcotics if deemed necessary.
    Other Names:
  • buddy taping
  • finger splint
  • tylenol
  • narcotics
  • Outcome Measures

    Primary Outcome Measures

    1. wrist flexion [initial]

      degrees of wrist flexion

    2. wrist flexion [3 weeks]

      degrees of wrist flexion

    3. wrist flexion [6 weeks]

      degrees of wrist flexion

    4. wrist flexion [12 weeks]

      degrees of wrist flexion

    5. wrist extension [12 weeks]

      degrees of wrist extension

    6. wrist extension [6 weeks]

      degrees of wrist extension

    7. wrist extension [3 weeks]

      degrees of wrist extension

    8. wrist extension [initial]

      degrees of wrist extension

    9. hand supination [initial]

      degrees of hand supination

    10. hand supination [3 weeks]

      degrees of hand supination

    11. hand supination [6 weeks]

      degrees of hand supination

    12. hand supination [12 weeks]

      degrees of hand supination

    13. hand pronation [initial]

      degrees of hand pronation

    14. hand pronation [3 weeks]

      degrees of hand pronation

    15. hand pronation [6 weeks]

      degrees of hand pronation

    16. hand pronation [12 weeks]

      degrees of hand pronation

    17. wrist ulnar deviation [initial]

      degrees of wrist ulnar deviance

    18. wrist ulnar deviation [3 weeks]

      degrees of wrist ulnar deviance

    19. wrist ulnar deviation [6 weeks]

      degrees of wrist ulnar deviance

    20. wrist ulnar deviation [12 weeks]

      degrees of wrist ulnar deviance

    21. wrist radial deviation [initial]

      degrees of radial deviance of the wrist

    22. wrist radial deviation [3 weeks]

      degrees of radial deviance of the wrist

    23. wrist radial deviation [6 weeks]

      degrees of radial deviance of the wrist

    24. wrist radial deviation [12 weeks]

      degrees of radial deviance of the wrist

    25. MCP, DIP, PIP of digits 2-5: Flexion [initial]

      degrees of flexion for MCP, DIP, and PIP of digits 2-5

    26. MCP, DIP, PIP of digits 2-5: Flexion [3 weeks]

      degrees of flexion for MCP, DIP, and PIP of digits 2-5

    27. MCP, DIP, PIP of digits 2-5: Flexion [6 weeks]

      degrees of flexion for MCP, DIP, and PIP of digits 2-5

    28. MCP, DIP, PIP of digits 2-5: Flexion [12 weeks]

      degrees of flexion for MCP, DIP, and PIP of digits 2-5

    29. MCP, DIP, PIP of digits 2-5: Extension [initial]

      degrees of extension for MCP, DIP, and PIP of digits 2-5

    30. MCP, DIP, PIP of digits 2-5: Extension [3 weeks]

      degrees of extension for MCP, DIP, and PIP of digits 2-5

    31. MCP, DIP, PIP of digits 2-5: Extension [6 weeks]

      degrees of extension for MCP, DIP, and PIP of digits 2-5

    32. MCP, DIP, PIP of digits 2-5: Extension [12 weeks]

      degrees of extension for MCP, DIP, and PIP of digits 2-5

    33. MCP, DIP, PIP of digits 2-5: abduction [initial]

      degrees of abduction for MCP, DIP, and PIP of digits 2-5

    34. MCP, DIP, PIP of digits 2-5: abduction [3 weeks]

      degrees of abduction for MCP, DIP, and PIP of digits 2-5

    35. MCP, DIP, PIP of digits 2-5: abduction [6 weeks]

      degrees of abduction for MCP, DIP, and PIP of digits 2-5

    36. MCP, DIP, PIP of digits 2-5: abduction [12 weeks]

      degrees of abduction for MCP, DIP, and PIP of digits 2-5

    37. MCP, DIP, PIP of digits 2-5: adduction [initial]

      degrees of adduction for MCP, DIP, and PIP of digits 2-5

    38. MCP, DIP, PIP of digits 2-5: adduction [3 weeks]

      degrees of adduction for MCP, DIP, and PIP of digits 2-5

    39. MCP, DIP, PIP of digits 2-5: adduction [6 weeks]

      degrees of adduction for MCP, DIP, and PIP of digits 2-5

    40. MCP, DIP, PIP of digits 2-5: adduction [12 weeks]

      degrees of adduction for MCP, DIP, and PIP of digits 2-5

    41. Thumb Opposition at MCP [initial]

      degrees of thumb opposition

    42. Thumb Opposition at MCP [3 weeks]

      degrees of thumb opposition

    43. Thumb Opposition at MCP [6 weeks]

      degrees of thumb opposition

    44. Thumb Opposition at MCP [12 weeks]

      degrees of thumb opposition

    45. Thumb extension at IP [initial]

      degrees of thumb IP extension

    46. Thumb extension at IP [3 weeks]

      degrees of thumb IP extension

    47. Thumb extension at IP [6 weeks]

      degrees of thumb IP extension

    48. Thumb extension at IP [12 weeks]

      degrees of thumb IP extension

    49. Thumb flexion at IP [initial]

      degrees of thumb IP flexion

    50. Thumb flexion at IP [3 weeks]

      degrees of thumb IP flexion

    51. Thumb flexion at IP [6 weeks]

      degrees of thumb IP flexion

    52. Thumb flexion at IP [12 weeks]

      degrees of thumb IP flexion

    53. Quick DASH Questionnaire [6 weeks]

      patient-reported outcome survey that evaluates functionality and patient-perceived disability

    54. Quick DASH Questionnaire [12 weeks]

      patient-reported outcome survey that evaluates functionality and patient-perceived disability

    Secondary Outcome Measures

    1. VAS Pain Scale [3 weeks]

      visual analog pain scale

    2. VAS Pain Scale [6 weeks]

      visual analog pain scale

    3. VAS Pain Scale [12 weeks]

      visual analog pain scale

    4. Complications [3 weeks]

      list of adverse events

    5. Complications [6 weeks]

      list of adverse events

    6. Complications [12 weeks]

      list of adverse events

    7. Edema Measurements [3 weeks]

      measurements of noted edema to the study area

    8. Edema Measurements [6 weeks]

      measurements of noted edema to the study area

    9. Edema Measurements [12 weeks]

      measurements of noted edema to the study area

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with soft tissue injuries and stable fractures from the metacarpophalangeal joint to the distal phalanx
    Exclusion Criteria:
    • Patients at increased risk of serious side effects of steroid administration.

    • Patients unable to provide consent

    • Unable to swallow oral medications

    • Pregnant women

    • ages less than 18 years old

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brielle Orthopedics Brick New Jersey United States 08724
    2 University Orthopedics Associates Somerset New Jersey United States 08873

    Sponsors and Collaborators

    • Robert Wood Johnson Barnabas Health
    • Brielle Orthopedics
    • University Orthopedics Associates

    Investigators

    • Principal Investigator: Brian Katt, MD, Rutgers, The State University of New Jersey

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Bobby Varghese, Co-Investigator, Robert Wood Johnson Barnabas Health
    ClinicalTrials.gov Identifier:
    NCT05003596
    Other Study ID Numbers:
    • Pro2021000732
    First Posted:
    Aug 12, 2021
    Last Update Posted:
    Aug 12, 2021
    Last Verified:
    Aug 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    Yes
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 12, 2021